Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 196.215 USD 1.05%
Market Cap: 41.8B USD

Wall Street
Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 217.329 USD with a low forecast of 145.652 USD and a high forecast of 268.8 USD.

Lowest
Price Target
145.652 USD
26% Downside
Average
Price Target
217.329 USD
11% Upside
Highest
Price Target
268.8 USD
37% Upside
Insmed Inc Competitors:
Price Targets
CSL
CSL Ltd
38% Upside
GLTO
Galecto Inc
17% Upside
AZT
Arcticzymes Technologies ASA
74% Upside
TVTX
Travere Therapeutics Inc
23% Upside
300676
BGI Genomics Co Ltd
31% Upside
VTGN
VistaGen Therapeutics Inc
225% Upside
QURE
Uniqure NV
173% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Insmed Inc

For the last 13 years the compound annual growth rate for Insmed Inc's revenue is 40%. The projected CAGR for the next 3 years is 81%.

40%
Past Growth
81%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INSM's stock price target?
Price Target
217.329 USD

According to Wall Street analysts, the average 1-year price target for INSM is 217.329 USD with a low forecast of 145.652 USD and a high forecast of 268.8 USD.

What is Insmed Inc's Revenue forecast?
Projected CAGR
81%

For the last 13 years the compound annual growth rate for Insmed Inc's revenue is 40%. The projected CAGR for the next 3 years is 81%.

Back to Top